CVS Health said on Monday it would add four new members to its board in an agreement with Glenview Capital Management, including the hedge fund's chief executive Larry Robbins.

Among the new CVS directors is Larry Robbins, chief executive of the hedge fund, which recently took a stake in the ...

StockNews.com cut shares of CVS Health (NYSE:CVS – Free Report) from a hold rating to a sell rating in a research note issued to investors on Thursday morning. Several other brokerages have also ...

Ad content in partnership with CVS. You’re not rushing the season (even if your Christmas tree is already up), because any way you look at it, the holidays are right around the corner! With ...

Walgreens’ woes are about more than an iconic Chicago company’s future. Our health is at stake, too. Walgreens Boots Alliance has a storied history in Chicago, starting with a ...

The period in which you can switch your Medicare Part D Plan or Medicare Advantage plan ends Dec. 7. Experts say it’s vital ...

Harbour Investments Inc. lowered its stake in shares of CVS Health Co. (NYSE:CVS – Free Report) by 5.3% in the third quarter, ...

Last fall, Chris Kinkade and his wife compared Medicare Advantage plans to find one that allowed them to see their preferred ...

The District 60 Board of Education unanimously approved a resolution hiring the Frantz Law Group Tuesday at the Lincoln Center administration building in Waukegan to help it recoup some of the ...

So far this month -- the Rochester area has seen four Walgreens pharmacy stores shutdown, citing financial issues.13WHAM ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $68.4, with a high ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $58.00.